跳轉至內容
Merck
全部照片(1)

文件

47768

Supelco

麦角钙化甾醇 (D2)

analytical standard

同義詞:

麦角钙化醇, 照射麦角甾醇, 维生素 D2, 钙化醇, 骨化醇

登入查看組織和合約定價
全部照片(1)

About This Item

經驗公式（希爾表示法）:
C28H44O
CAS號碼:
50-14-6
分子量：:
396.65
Beilstein:
1916682
EC號碼:
200-014-9
MDL號碼:
MFCD00166988
分類程式碼代碼:
12164500
PubChem物質ID:
24871402

等級

analytical standard

CofA

current certificate can be downloaded

特點

standard type fat soluble vitamin

包裝

ampule of 100 mg

技術

HPLC: suitable
gas chromatography (GC): suitable

顏色

white to yellowish

mp

114-118 °C (lit.)

應用

agriculture
cleaning products
cosmetics
environmental
food and beverages
personal care
pharmaceutical (small molecule)
vitamins, nutraceuticals, and natural products

格式

neat

運輸包裝

wet ice

儲存溫度

−20°C

SMILES 字串

CC(C)[C@@H](C)/C=C/[C@@H](C)[C@@]1([H])CC[C@@]([C@]1(C)CCC/2)([H])C2=C\C=C(C[C@@H](O)CC3)/C3=C

InChI

1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1

InChI 密鑰

MECHNRXZTMCUDQ-RKHKHRCZSA-N

基因資訊

human ... VDR(7421)

尋找類似的產品？ 前往 產品比較指南

應用

有关合适仪器技术的更多信息，请参考产品的分析证书。如需进一步支持，请联系技术服务。

相關產品

產品號碼
描述
訂價

象形圖

Skull and crossbonesHealth hazard
GHS06,GHS08

訊號詞

Danger

危險分類

Acute Tox. 2 Inhalation - Acute Tox. 3 Dermal - Acute Tox. 3 Oral - STOT RE 1 Oral

儲存類別代碼

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

個人防護裝備

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

Choose from one of the most recent versions:

分析證明 (COA)

Lot/Batch Number
LRAB7469
LC26541V
LC25901V
LC25001V
LC23265V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Michael P Boyle et al.
American journal of respiratory and critical care medicine, 172(2), 212-217 (2005-04-30)
Treatment guidelines for vitamin D monitoring and supplementation in cystic fibrosis (CF) have recently been developed and published by a consensus committee, but have not been prospectively tested. To use these guidelines to determine the percentage of adults with CF
B L Salle et al.
The American journal of clinical nutrition, 71(5 Suppl), 1317S-1324S (2000-05-09)
During pregnancy, maternal serum concentrations of 25-hydroxyvitamin D, the circulating form of vitamin D, correlate with dietary vitamin D intake. Maternal serum concentrations of 1,25-dihydroxyvitamin D, the hormonal circulating and active form of vitamin D, are elevated during pregnancy; 1,25-dihydroxyvitamin
G Jones et al.
Physiological reviews, 78(4), 1193-1231 (1998-10-28)
The important reactions that occur to the vitamin D molecule and the important reactions involved in the expression of the final active form of vitamin D are reviewed in a critical manner. After an overview of the metabolism of vitamin
H A Bischoff et al.
The Histochemical journal, 33(1), 19-24 (2001-05-16)
Growing evidence suggests that intracellular vitamin D receptors are present in skeletal muscle tissue mediating vitamin D hormone response. The aim of the work reported here was to investigate the in situ expression of 1,25-dihydroxyvitamin D3 receptor in human skeletal
Pentti Tuohimaa et al.
International journal of cancer, 108(1), 104-108 (2003-11-18)
Vitamin D inhibits the development and growth of prostate cancer cells. Epidemiologic results on serum vitamin D levels and prostate cancer risk have, however, been inconsistent. We conducted a longitudinal nested case-control study on Nordic men (Norway, Finland and Sweden)
查看所有相關論文

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務